Why Membrane Matters In AAV Filtration: Comparing Spectrum® 100 kD mPES And Competitor PS Membrane Hollow Fiber Filters

Gene therapy holds extraordinary promise as a one-time treatment capable of transforming lives. Many human diseases stem from defective genes, and the success of gene therapy depends on our ability to precisely correct these genetic errors within the appropriate tissues. To achieve this, scientists have explored various techniques, with adeno-associated virus (AAV) vectors emerging as a leading option due to their non-pathogenic nature, broad tissue tropism, low immunogenicity, and ability to deliver long-lasting gene expression. As gene therapy continues to advance, optimizing AAV manufacturing and purification is critical to making these treatments more accessible and cost-effective.

If you're involved in biotech, research, or healthcare innovation, now is the time to explore how you can contribute to or benefit from the evolving landscape of gene therapy.